FDA Inspection
Fayz A. Hudefi, M.D.FDA Inspection 1249620 - Fayz A. Hudefi, M.D. - September 20, 2024
Record Details
This FDA Inspection record concerns Fayz A. Hudefi, M.D., with an inspection on September 20, 2024, issued by the Dallas District Office, covering human drugs.
View Company Profile
ID · 90a08b74-1c3e-4b32-a605-553dc5b98901
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1249620
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring: Human Drugs
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Fayz A. Hudefi, M.D.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| April 21, 2023 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 16, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Fayz A. Hudefi, M.D.
- FDA Inspection 1204113 - 2023-04-21
- FDA Inspection 1131413 - 2020-09-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.